These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 141627)
1. Computed tomography for Huntington's disease. Terrence CF; Delaney JF; Alberts MC Neuroradiology; 1977 Jun; 13(4):173-5. PubMed ID: 141627 [TBL] [Abstract][Full Text] [Related]
2. Neuropathologic correlation of computerized tomography in Huntington's disease. Terrence CF; Rao G South Med J; 1980 Jun; 73(6):817-8. PubMed ID: 6446759 [TBL] [Abstract][Full Text] [Related]
3. Bicaudate diameter--the most specific and simple CT parameter in the diagnosis of Huntington's disease. Stober T; Wussow W; Schimrigk K Neuroradiology; 1984; 26(1):25-8. PubMed ID: 6234475 [TBL] [Abstract][Full Text] [Related]
4. Measurement of caudate nucleus area--a more accurate measurement for Huntington's disease? Wardlaw JM; Sellar RJ; Abernethy LJ Neuroradiology; 1991; 33(4):316-9. PubMed ID: 1833664 [TBL] [Abstract][Full Text] [Related]
5. Correlation between triplet repeat expansion and computed tomography measures of caudate nuclei atrophy in Huntington's disease. Culjkovic B; Stojkovic O; Vojvodic N; Svetel M; Rakic L; Romac S; Kostic V J Neurol; 1999 Nov; 246(11):1090-3. PubMed ID: 10631644 [TBL] [Abstract][Full Text] [Related]
6. Is direct CT caudatometry superior to indirect parameters in confirming Huntington's disease? Lang C Neuroradiology; 1985; 27(2):161-3. PubMed ID: 3157882 [TBL] [Abstract][Full Text] [Related]
7. Neuropsychological and neuroradiological correlates in Huntington's disease. Starkstein SE; Brandt J; Folstein S; Strauss M; Berthier ML; Pearlson GD; Wong D; McDonnell A; Folstein M J Neurol Neurosurg Psychiatry; 1988 Oct; 51(10):1259-63. PubMed ID: 2976080 [TBL] [Abstract][Full Text] [Related]
8. Atrophy of caudate nucleus in Huntington's disease measured by computed tomography. Roth J; Havrdová E; Růzicka E J Neurol; 2000 Nov; 247(11):880-1. PubMed ID: 11151423 [No Abstract] [Full Text] [Related]
9. Serial changes of cerebral glucose metabolism and caudate size in persons at risk for Huntington's disease. Grafton ST; Mazziotta JC; Pahl JJ; St George-Hyslop P; Haines JL; Gusella J; Hoffman JM; Baxter LR; Phelps ME Arch Neurol; 1992 Nov; 49(11):1161-7. PubMed ID: 1444883 [TBL] [Abstract][Full Text] [Related]
10. Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease. Antonini A; Leenders KL; Spiegel R; Meier D; Vontobel P; Weigell-Weber M; Sanchez-Pernaute R; de Yébenez JG; Boesiger P; Weindl A; Maguire RP Brain; 1996 Dec; 119 ( Pt 6)():2085-95. PubMed ID: 9010012 [TBL] [Abstract][Full Text] [Related]
11. Computerized tomography in amyotrophic choreo-acanthocytosis. Serra S; Xerra A; Scribano E; Meduri M; Di Perri R Neuroradiology; 1987; 29(5):480-2. PubMed ID: 2960913 [TBL] [Abstract][Full Text] [Related]
13. [The CT image of atrophy of the head of the caudate nucleus in Huntington's chorea]. Roth J; Havrdová E; Stiková V; Bauer J Cas Lek Cesk; 1996 May; 135(9):277-9. PubMed ID: 8706085 [TBL] [Abstract][Full Text] [Related]
14. CT brainstem abnormalities in the differential diagnosis of Huntington's disease. Masucci EF; Borts FT; Kurtzke JF Comput Med Imaging Graph; 1990; 14(3):205-12. PubMed ID: 2140710 [TBL] [Abstract][Full Text] [Related]